Four years on from the devastating Lismore floods the disaster recovery program that followed is being wound down. Hundreds of millions of dollars have been spent on a house buyback program. And while ...
Cardinal Health, Inc. CAH reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.63, which beat the Zacks Consensus Estimate of $2.39 by 10%. The bottom line also improved 36.3% ...
DUBLIN, Ohio, Jan. 13, 2026 /PRNewswire/ -- Cardinal Health today provided an update to its financial outlook for fiscal year 2026 and plans to highlight significant progress with its strategic growth ...
Vibe coding — the fast-growing trend of using generative AI to spin up code from plain-language prompts — is quick, creative, and great for instant prototypes. But many argue that it's not cut out for ...
The T32 grant provides full-time research training support for post-candidacy predoctoral learners pursuing mentored clinical and translational research or clinical and translational science who are ...
On October 3, 2025, the U.S. Food and Drug Administration (FDA) announced a prioritization pilot program for reviewing abbreviated new drug applications (ANDAs). ANDAs are submissions for generic ...
The U.S. Food and Drug Administration said on Friday that it has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in the United ...
Add Yahoo as a preferred source to see more of our stories on Google. A U.S. flag, a U.S. Food and Drug Administration (FDA) logo, a syringe and a vial are seen in this illustration taken May 13, 2025 ...
A U.S. flag, a U.S. Food and Drug Administration (FDA) logo, a syringe and a vial are seen in this illustration taken May 13, 2025. REUTERS/Dado Ruvic/Illustration (Reuters) -The U.S. Food and Drug ...
Against a backdrop of tariff updates and a drug pricing deal from the Trump administration, the FDA charted a pair of moves this week in its push to make drug manufacturing more attractive in the U.S.
The FDA is launching a new pilot prioritization program for the review of abbreviated new drug applications that would provide faster reviews for generic companies that test and manufacture their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results